| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.03 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |